Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome associated
with poor quality of life, substantial health-care resource utilization, and premature mortality …

The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Aims The aims of this study were to assess prescription patterns, dosages, discontinuation
rates, and association with prognosis of conventional heart failure medications in patients …

Background The risk of sudden death has changed over time among patients with
symptomatic heart failure and reduced ejection fraction with the sequential introduction of …

Sudden cardiac death (SCD) from cardiac arrest is a major international public health
problem accounting for an estimated 15%–20% of all deaths. Although resuscitation rates …

Aims The angiotensin-receptor-neprilysin inhibitor (ARNI) LCZ696 reduced cardiovascular
deaths and all-cause mortality compared with enalapril in patients with chronic heart failure …

Sudden cardiac death (SCD) remains a daunting problem. It is a major public health issue
for several reasons: from its prevalence (20% of total mortality in the industrialized world) to …

Aims A substantial proportion of patients with heart failure have preserved left ventricular
ejection fraction (HF-PEF). Previous studies have reported mixed results whether survival is …

Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …